Clinical trial · Interventional
Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Multicenter Prospective Clinical Trial to Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
NCT03432117CI-TRIAL-00031860completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COPD | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Respiratory Disease | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fixed respiratory rehabilitation | Other | — | UNRESOLVED |
| Responsive respiratory rehabilitation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Fixed respiratory rehabilitation program(A)
- description
- respiratory rehabilitation program for 12 weeks
- interventionNames
- Other: Fixed respiratory rehabilitation
- type
- EXPERIMENTAL
- label
- Mixed respiratory rehabilitation program(B)
- description
- Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks
- interventionNames
- Other: Fixed respiratory rehabilitation
- Other: Responsive respiratory rehabilitation
- type
- NO_INTERVENTION
- label
- Control(C)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with Lung cancer or COPD * Patients with FEV1\<80% or FVC\<80% in Pulmonary function test * In case of COPD, post-bronchodilator FEV1 or FVC will be used. * Exceptionally Lung Cancer patients with operation, FEV1\>80% or FVC\>80% will be permitted * The distance walked for 6 minutes in 6-minute walk test ≥ 150 m * Patients with android phone * Patients who voluntarily agree to study participation and provide written informed consent form Exclusion Criteria: * Patients with diseases which could be cause of death or significant disability for 1 year after study enrollment. * Patients with diseases that are difficult to walk or improve walking at screening * Patients with significant diseases which are difficult to include in this study in accordance with the investigator's judgment * Patients who are illiterate or have communication limitations * Patients who have a difficulty to complete a questionnaire or are uncooperative due to deterioration of recognition function
References
Publications (2)
- DERIVEDCox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2. PMID 33511633
- DERIVEDKwon H, Lee S, Jung EJ, Kim S, Lee JK, Kim DK, Kim TH, Lee SH, Lee MK, Song S, Shin K. An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Aug 24;6(8):e10502. doi: 10.2196/10502. PMID 30143475